Explore the groundbreaking work of Cecile Pickart, who decoded the language of ubiquitin and revolutionized our understanding of cellular regulation.
Discover how scientists systematically validate reference genes to ensure accurate gene expression studies in pears, from sweetness to disease resistance.
Discover how APC-targeted RAA1 degradation regulates cell cycle progression and root architecture in plants through the ubiquitin-proteasome system.
Discover how Querétaro researchers are validating IRF6 and SUMO1 as genetic markers for non-syndromic cleft lip and palate in the local population.
Discover how FBXO8, a tiny protein, correlates with tumor grade and prognosis in human glioma, offering new hope for brain cancer treatment.
Exploring how targeting deubiquitinating enzymes (DUBs) associated with the proteasome could revolutionize ovarian cancer treatment by overcoming drug resistance.
Exploring the fascinating relationship between DUB/USP17 deubiquitinating enzymes and the beta-defensin cluster in human genetics and disease.
Explore how predictive biomarkers are transforming the diagnosis and treatment of traumatic brain injury, improving patient outcomes through personalized medicine.
Discover how multi-omics research identified p21-activated kinase signaling as a key driver of colitis, opening new therapeutic possibilities for inflammatory bowel disease.
Discover how Cbl-b deficiency makes T cells resistant to PD-L1-mediated inhibition and its implications for cancer immunotherapy.